Zai Lab Limited

Direct answer

Zai Lab Limited is publicly traded on NASDAQ under the ticker ZLAB.

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA for acute bacterial skin and skin structure infections, and community...

Can you invest in Zai Lab Limited?

Yes. Zai Lab Limited shares can be bought through brokers that offer access to listed stocks.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Zai Lab Limited

Detailed equity research is provided by MarketSnap.